Abstract
Single-cell analyses of colon biopsy specimens from patients with ulcerative colitis delineate how expression patterns and shifting cell populations may shape disease and drug resistance, and provide a framework for linking GWAS risk loci with specific cell types and functional pathways.
Original language | American English |
---|---|
Pages (from-to) | 714-730.e22 |
Journal | Cell |
Volume | 178 |
Issue number | 3 |
DOIs | |
State | Published - 25 Jul 2019 |
Externally published | Yes |
Bibliographical note
Funding Information:We thank all consenting participants of this study, the clinical staff at Massachusetts General Hospital, Leslie Gaffney and Anna Hupalowska for help with figures, Tim Tickle for help with the Single Cell Portal, Vijay Yajnik, Frank Colizzo, and Abdifatah Omer. M.B. was supported by a postdoctoral fellowship from the Human Frontiers Science Program . J.O.-M. is an HHMI Damon Runyon Cancer Research Foundation Fellow ( DRG-2274-16 ). Work was supported by the Klarman Cell Observatory (to A.R. and R.J.X.); HHMI (to A.R.); the Manton Foundation (to A.R. and R.X.); Broadnext10 (to A.R. and R.J.X.); DK043351 , DK114784 , DK117263 , the Helmsley Charitable Trust , and the Crohn's and Colitis Foundation (to R.J.X.); a Sloan Fellowship in Chemistry (to A.K.S.); the Searle Scholars Program (to A.K.S.); the Beckman Young Investigator Program (to A.K.S.); and NIH 5U24AI118672 (to A.R. and A.K.S.). This publication is part of the Human Cell Atlas.
Funding Information:
We thank all consenting participants of this study, the clinical staff at Massachusetts General Hospital, Leslie Gaffney and Anna Hupalowska for help with figures, Tim Tickle for help with the Single Cell Portal, Vijay Yajnik, Frank Colizzo, and Abdifatah Omer. M.B. was supported by a postdoctoral fellowship from the Human Frontiers Science Program. J.O.-M. is an HHMI Damon Runyon Cancer Research Foundation Fellow (DRG-2274-16). Work was supported by the Klarman Cell Observatory (to A.R. and R.J.X.); HHMI (to A.R.); the Manton Foundation (to A.R. and R.X.); Broadnext10 (to A.R. and R.J.X.); DK043351, DK114784, DK117263, the Helmsley Charitable Trust, and the Crohn's and Colitis Foundation (to R.J.X.); a Sloan Fellowship in Chemistry (to A.K.S.); the Searle Scholars Program (to A.K.S.); the Beckman Young Investigator Program (to A.K.S.); and NIH 5U24AI118672 (to A.R. and A.K.S.). This publication is part of the Human Cell Atlas. M.B. and J.O.-M. designed and performed experiments with A.K.S. R.J.X. A.N.A. A.R. G.B. N.R. M. Slyper, J.W. M. Sud, S.V. J.Y. E.A.C. and A.N.D. C.S.S. designed and performed computational analyses with A.R. R.J.X. D.B.G. R.H.H. A.L.H. K.J. A.-C.V. M.H. H.H. M.B. J.O.-M. and M.J.D. K.M.S. E.A. and G.V. performed clinical work with C.S. J.J.G. H.K. A.N.A. and R.J.X. D.D. L.T.N. and O.R.-R. assisted with scRNA-seq. C.S.S. M.B. J.O.-M. A.K.S. R.J.X. and A.R. wrote the manuscript with input from all authors. A.R. is an SAB member of Thermo Fisher Scientific and Syros Pharmaceuticals. A.R. and R.J.X. are cofounders of and equity holders in Celsius Therapeutics. R.J.X. is a consultant to Novartis. A.K.S is compensated for consulting and SAB membership by Honeycomb Biotechnologies, Dot Bio, Cellarity, Cogen Therapeutics, and Dahlia Biosciences. M.B. A.L.H. N.R. R.H.H. J.O.-M. O.R.-R. A.K.S. K.S. C.S.S. A.R. and R.J.X. are co-inventors on PCT/US2018/042554 relating to advances in understanding cellular dynamics, cellular effectors, and risk variants of the human colon in health and UC described in this manuscript.
Publisher Copyright:
© 2019 Elsevier Inc.
Keywords
- anti-TNF resistance
- cell-cell interactions
- colon
- genome-wide association studies
- inflammation
- inflammatory bowel disease
- large intestine
- single-cell RNA-seq
- single-cell genomics
- ulcerative colitis